Completed NA INTERVENTIONAL 2-arm NCT03667443

Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients

The Effects of Myo-inositol Plus Alpha-lactalbumin in Ovulation Induction of PCOS Myo-inositol-resistant Patients

Sponsor: Lo.Li.Pharma s.r.l

Interventions Myo-inositol + folic a. Myo-inositol + folic a. + α-lactalbumin

Updated 7 times since 2018 Last updated: Jul 8, 2025 Started: Jun 13, 2022 Primary completion: Oct 26, 2022 Completion: Dec 19, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Myo-inositol-resistance and PCOS and is currently completed. Lo.Li.Pharma s.r.l leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Aug 2025 — Present [monthly]

Completed NA

Status: Withdrawn → Completed
Sep 2024 — Aug 2025 [monthly]

Withdrawn NA
Jul 2024 — Sep 2024 [monthly]

Withdrawn NA
May 2022 — Jul 2024 [monthly]

Withdrawn NA

Status: Unknown Status → Withdrawn
Jan 2021 — May 2022 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Oct 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Oct 2018 — Oct 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lo.Li.Pharma s.r.l

Data source: Lo.Li.Pharma s.r.l

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sofia, Bulgaria